Upstream Bio, Inc. (UPB)
2.74
-0.25
(-8.36%)
USD |
NASDAQ |
Oct 23, 16:00
2.735
0.00 (0.00%)
After-Hours: 20:00
Upstream Bio Profit Margin (Quarterly) : -5.14K% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -5.14K% |
| March 31, 2026 | -3.93K% |
| December 31, 2025 | -6.36K% |
| September 30, 2025 | -4.94K% |
| Date | Value |
|---|---|
| June 30, 2025 | -4.27K% |
| March 31, 2025 | -4.82K% |
| December 31, 2024 | -3.47K% |
| September 30, 2024 | -2.63K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Sutro Biopharma, Inc. | -391.6% |
| ACADIA Pharmaceuticals, Inc. | 10.23% |
| Alnylam Pharmaceuticals, Inc. | 12.74% |
| Anika Therapeutics, Inc. | 10.15% |
| Savara, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -45.97% |
| Return on Assets | -44.34% |
| Return on Invested Capital | -45.80% |
| Gross Profit Margin (Quarterly) | 93.53% |
| Operating Margin (Quarterly) | -5.48K% |
| Return on Net Operating Assets | -895.9% |